language_icon
EN
HI

Medicamen Organics Share price

MEDIORG

29.2

0.45 (-1.52%)
Last updated on 24 Apr, 2026 | 13:44 IST
Today's High

29.20

Today's Low

29.20

52 Week Low

20.05

52 Week High

49.70

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Medicamen Organics Chart

Medicamen Organics Share Key Metrics

Volume
6000.00
Market Cap
34.69 CR
LTQ@LTP
2000@29.20
ATP
29.2
Var Margin
53.5 %
Circuit Range
26.7-32.6
Delivery %
- %
Value
1.75 L
ASM/GSM
No
Market Lot
2000

Summary

Medicamen Organics share price stands at ₹29.2 at 24 Apr, 2026 | 13:44. The stock Medicamen Organics intraday movement has stayed between ₹29.20 and ₹29.20, while on a 52-week basis it has fluctuated from ₹20.05 to ₹49.70.
In terms of trading activity, Medicamen Organics has recorded a volume of 6000 shares. The Medicamen Organics has a market cap of ₹11700000. The stock’s Average Traded Price (ATP) stands at ₹2920, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2000, 2920.
The Medicamen Organics operates within a circuit range of ₹26.7-32.6 – ₹26.7-32.6, with a Value of ₹1.75 L. The Delivery Percentage for the day is -1%. Additionally, Medicamen Organics currently falls under the No framework, and trades with a market lot size of 2000.

Medicamen Organics Fundamentals

View More
P/E Ratio

8.44

P/B Ratio

1.16

Div. Yield

0

Sector P/E

63.82

Sector P/B

3.5

Sec. Div. Yield

0.57

Medicamen Organics Resistance and Support

Pivot 29.65

Resistance

First Resistance

29.65

Second Resistance

29.65

Third Resistance

29.65

Support

First Support

29.65

Second Support

29.65

Third Support

29.65

Medicamen Organics Shareholding Pattern

View More
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

59.73%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.07%

Domestic Institutional Investors

1.64%

Retail

38.56%

Others

0%

Total Promoters
MAR '26
59.73%

Medicamen Organics Corporate Actions

DateAgenda
2026-03-13To consider Fund Raising
2025-11-14Quarterly Results

Medicamen Organics News

Medicamen Organics Limited (MEDIORG)

Medicamen Organics submitted the Structured Digital Database (SDD) Compliance Certificate for the financial year ended March 31, 2026. The company confirmed full adherence to SEBI (Prohibition of Insider Trading) Regulations, capturing all 19 required events with no non-compliance observed.
Apr 23 2026 16:04:00

Medicamen Organics Limited (MEDIORG)

Medicamen Organics appointed Divya Sharma as Company Secretary, effective April 17, 2026. This appointment reinforces corporate governance and statutory compliance with her decade of experience in manufacturing and IT.
Apr 17 2026 17:04:00

Medicamen Organics Limited

Medicamen Organics appointed Ms. Divya Sharma as Company Secretary & Compliance Officer. The Board also authorized Key Managerial Personnel to determine the materiality of events for stock exchange disclosures, effective from the meeting on April 17, 2026.
Apr 17 2026 16:04:00

Medicamen Organics Limited (MEDIORG)

Medicamen Organics Limited appointed Ms. Divya Sharma as Company Secretary & Compliance Officer, effective April 17, 2026. This appointment, approved by the board, is based on the Nomination and Remuneration Committee's recommendation, enhancing corporate governance.
Apr 17 2026 16:04:00

Medicamen Organics Limited (MEDIORG)

Medicamen Organics announced that Varsha Bansal ceased to be the Company Secretary effective April 16, 2026. This change impacts the company's key managerial personnel structure.
Apr 16 2026 20:04:00

Medicamen Organics Limited (MEDIORG)

Medicamen Organics announces the resignation of Ms. Varsha Bansal as Company Secretary & Compliance Officer, effective April 16, 2026. She served as a Key Managerial Personnel.
Apr 16 2026 18:04:00

Medicamen Organics Limited (MEDIORG)

Medicamen Organics states it is not a 'Large Corporate' as per SEBI guidelines as of March 31, 2026. This means the company is exempt from disclosure and compliance requirements for debt security fund-raising applicable to large entities.
Apr 15 2026 12:04:00

Medicamen Organics Limited (MEDIORG)

Medicamen Organics clarified to the NSE that the recent increase in its share price is solely due to market forces. The company confirmed it has not withheld any material or price-sensitive information.
Apr 13 2026 17:04:00

Medicamen Organics Limited (MEDIORG)

Medicamen Organics EGM approved increasing authorized share capital, preferential issue of up to 20 lakh equity shares to the public, and 11.86 lakh fully convertible warrants to both promoter and public categories. Additionally, it approved converting a loan into 7.14 lakh equity shares for the promoter.
Apr 10 2026 21:04:00

Medicamen Organics Limited (MEDIORG)

Medicamen Organics EGM approved a significant capital restructuring. This includes increasing authorized capital, a preferential issue of 20 lakh equity shares, and issuing 11.86 lakh warrants. Additionally, a loan will be converted into 7.14 lakh equity shares for promoters, strengthening the company's financial base.
Apr 09 2026 19:04:00
Read More

About Medicamen Organics

NSE : 24239  
BSE : 0  
ISIN : INE0PE401018  

Our Company was incorporated on March 15 1995 as ‘Panchdeep Pharmaceuticals Limited’ a public limited company under the Companies Act 1956 pursuant to a certificate of incorporation dated March 15 1995 issued by the Registrar of Companies National Capital Territory (NCT) of Delhi and Haryana. Our Company has received Certificate of Commencement of Business on March 15 1995 1995 issued by the Registrar of Companies National Capital Territory (NCT) of Delhi and Haryana. Subsequently pursuant to a resolution passed by the Board of Directors in their meeting held on July 31 1995 and by the Shareholders in their EGM held on October 14 1995 the name of our Company was changed to ‘Medicamen Organics Limited’ and a fresh certificate of incorporation dated November 14 1995 was issued by the Registrar of Companies Delhi and Haryana at Delhi. The corporate identification number of our Company is U74899DL1995PLC066416.Major Events and Milestones1995-Our Company was incorporated as a Public Limited company under the name “Panchdeep Pharmaceuticals Limited” and later the company has changed its name from “Panchdeep Pharmaceuticals Limited” to “Medicamen Organics Limited”.1996 -We started with trading of pharmaceuticals for supplies to various Government departments.1998-We took loan license with ‘M/s Rhydurg Pharmaceuticals’ a unit situated in Kundali across the border of Delhi and started getting product manufactured for our marketing.2007- We purchased a plot of land measuring 1200 square meter from SIDCUL Industrial Authority in Haridwar and started construction for our own pharma unit. The construction of three-storeyed building (including basement measuring 15000 sq. feet was completed and we got our own manufacturing license for tablets capsules oral liquids in form 25 and 28 and started our own production in the same year (UNIT-I)-We received WHO/GMP Certificate for Unit I which is valid till today-We applied for a license for manufacturing of food supplements like protein powders vitamin tablets and syrups etc. and got our first license-We received WHO/GMP Certificate for Unit I which is valid till today-We got an opportunity to purchase one readymade adjacent unit to shift our food production in a separate unit. We got our first license in this Unit and tied up with renowned Pharma company for one of their renowned products for manufacturing in our plant. This unit was termed as (UNIT-II)-We stopped production of general pharma products in Unit-I and converted it into a unit for exclusive production of Iron Tablets because of its huge world-wide demand. For this purpose we entered into a joint venture with one Denish Company and gave them authority for worldwide export of our Iron Products. The joint venture company in turn got 50% equity in our company. In the year 2017 we reconstructed Unit-II and created 20000 sq. feet area for production of tablets capsules oral liquids ointments and dry power veterinary medicines etc. and we got our first license for pharma in this unit.

Read More

Medicamen Organics Management

NamePosition
Bal Kishan GuptaManaging Director
Ashutosh GuptaWhole Time Director
View More

Medicamen Organics Similar Stocks

Medicamen Organics FAQs

The Buying Price of Medicamen Organics share is 29.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Medicamen Organics stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Medicamen Organics, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Medicamen Organics shares is 8.44. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Medicamen Organics shares is 1.16. Useful to assess the stock's value relative to its book value.

To assess Medicamen Organics’s valuation compare Sector P/E, P/B which are 63.82 & 3.5 with sector averages, along with growth rates and financial metrics.

The Market Cap of Medicamen Organics is 34.69 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Medicamen Organics share price is 49.70 & 20.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Medicamen Organics belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost